Personals Sign In / Join
Username:
 Password:
Back to home » Top Stories » IAS 2007

emailrssprint

Pipeline Preview: All The New AIDS Drugs Coming Soon

July 25, 2007

Peter Staley reviews all the new experimental AIDS drugs with Dr. Joe Eron, Professor of Medicine at the University of North Carolina at Chapel Hill. He discusses two experimental non-nukes, and two completely new classes of drugs: CCR5 inhibitors and integrase inhibitors.



14 1/2 minutes. Click here to view the transcript.

NEW! Scroll down to comment on this story.

emailrssprint


Name:

(2-50 characters)

Email:

(will not show)

City:

(optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include either ":" or "@" in your comment.)

| Posting Rules

Previous Comments:

comments 1 - 9 (of 9 total)    

Don Mathews, Salem, Oregon, 2007-08-11 02:33:39
Great interview Peter! I am very impressed with Dr. Eron and his knowledge base. It sure would be nice if the pharmaceutical companies would simplify their drug names. I've been poz 15 years and counting! Take care everyone.

Paul, Sydney, Australia, 2007-07-31 05:01:48
I've been living with HIV for 14 years. I have tolerated most of the antiretrovirals taken however resistance has always got in the way. This time last year my CD4 count had plumeted to 22 with VL of 542,000. I commenced the Integrase study and have been undetectable for 8 months with stable CD4 count in mid 200's...first time for several years. My participation in this study has now been extended by 2 years.

ben, Houston, 2007-07-29 12:49:05
Thank you for the posting. I'm glad I'm able to see and hear about all the new options and opportunities that are taking place in the science community. As always, Great Job!

Bryce Russell, Ft. Lauderdale, 2007-07-28 10:54:22
I found this video very informative. Presently I am participatin in the TMC-125 Etravirine phase 3 trials. Happily after 12 months on the study my viral load is untectable and my t-cells at 400 have remained constant. Additionally I have not suffered from any major side effects that make this drug less tolerable.

Mike, St.Louis, 2007-07-28 10:46:09
Hi. Ive been Hiv positive for 16 years and so far knock on wood meds on doing good. Thanks for the updates

Brad Vandergriff, Atlanta, Georgia, 2007-07-27 17:55:27
To Gene Borden of Pennsylvania I just wanted to let you know that when you get Medicare you can go to the Department of Human Services and apply for QMB program or Qualified Medicare Beneficiary which the state pays your premiums if you are unable to pay them and meet certain income guidelines.

Edward Pellien, Pittsburgh, 2007-07-27 06:26:04
For those HIV patients thinking these new classes of drugs are too good to be true, I can say I am a believer! Since being infected in 1983 from a blood transfusion, I've become resistant to most HIV drugs. With a viral load of over One Million, I began the Merck Integrase study in June of 2006.Suffering no side effects, I have achieved and maintained under 50 copies For over a year and feel great!

Robert Evans, New York, 2007-07-27 01:52:41
I'll let my Dr. take care of keeping track of this, especially at this very late hour when I several more emails to look at. But I'm happy that the arsenal for folks like myself continues to expand. Thanks, Dr. Eron and others.

Gene Borden, philadelphia, 2007-07-26 23:31:52
I still have a year before Iam eligible for medicare on my disability. Will medicare coverage cost me money?

comments 1 - 9 (of 9 total)    


[Go to top]


July 26, 2007
Beyond Condoms: Medical Approaches For Prevention
Regan Hofmann talks with Dr. Nancy Padian about PrEP, microbicides, and circumcision, and asks "when can my boyfriend and I stop using condoms."
July 25, 2007
Pipeline Preview: All The New AIDS Drugs Coming Soon
Peter Staley reviews all the new experimental AIDS drugs with Dr. Joe Eron, including two non-nukes, and two new classes of drugs: CCR5 and integrase inhibitors.
Simple Test Eliminates Abacavir Risk
Peter Staley asks Professor Simon Mallal from the Royal Perth Hospital about a simple new genetic test that accurately predicts if a patient is at risk for an allergic reaction to abacavir (Ziagen).
July 24, 2007
A Positive Papua New Guinean Speaks Out Against Stigma
Regan Hofmann interviews Maura Elaripe Mea, the first HIV-positive woman to come forward publicly in her country. Through Igat Hope, the national network of people living with HIV/AIDS in PNG, Maura and others fight AIDS discrimination while spreading information and hope.
The Latest on Lipo: Advances & Setbacks
Dr. Don Kotler discusses the latest from Sydney, both good and bad, on lipodystrophy treatments and cardiovascular risk in people with HIV.
Which HIV Meds Cause Lipoatrophy?
In this videocast, Dr. Eric Daar provides an overview of which nukes, non-nukes, and protease inhibitors might cause fat loss, and which ones probably won't.
Are We Starting Treatment Early Enough?
In this videocast, Dr. Fred Gordin explains why many experts think we might be waiting too long to put patients on HIV treatment.
July 23, 2007
An Eccentric Professor Expounds on Growing Old With HIV
A videocast interview with Professor Brian Gazzard, an expert on HIV and aging.
July 22, 2007
Fauci Defends Bush's AIDS Legacy
Peter Staley interviews Tony Fauci about his research on HIV "eradication," President Bush's AIDS legacy, why he likes gay men and Republicans, and that letter he wrote supporting Scooter Libby.


© 2008 Smart + Strong. All Rights Reserved. terms of use and your privacy